AG

Ajaykumar Govindbhai Patil

Active Director Designated Partner DIN 10037821
DIN 10037821 First appointment Jan 2023 Primary industry Information Technology
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Ajaykumar Govindbhai Patil

Data last updated:

Ajaykumar Govindbhai Patil is a Designated Partner at Curex Bio Research Llp (since 2023). The company operates in Information Technology.

DIN 10037821
Primary Designation Designated Partner
Industry Information Technology
First Appointment 10 Jan 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner10 Jan 20232023Active

Board colleagues of Ajaykumar Govindbhai Patil

NameDINCompanyDesignation
Purvi Ashokkumar Chavda10037820Curex Bio Research LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Curex Bio Research Llp
Premium access

Shareholding and investment profile for Ajaykumar Govindbhai Patil

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ajaykumar Govindbhai Patil

Ajaykumar Govindbhai Patil currently holds 1 directorship: Curex Bio Research Llp (Designated Partner, since 10 Jan 2023).

Ajaykumar Govindbhai Patil was first appointed on 10 Jan 2023 as Designated Partner at Curex Bio Research Llp.

The current boards of Ajaykumar Govindbhai Patil's companies include Purvi Ashokkumar Chavda (Curex Bio Research Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available